Aurobindo Pharma arm enters pact to form JV in China with Luoxin Industry-Economic Times — December 11, 2018 comments off “The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin,” Aurobindo Pharma said.
“The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin,” Aurobindo Pharma said.